Cited 5 times in
Survival Advantage of Icodextrin Peritoneal Dialysis Solution in a Time-Dependent Model
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 한승혁 | - |
dc.date.accessioned | 2014-12-18T08:22:05Z | - |
dc.date.available | 2014-12-18T08:22:05Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 0272-6386 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/86175 | - |
dc.description.abstract | The importance of immortal time in observational studies that have time-dependent treatment effects has been re-emphasized recently.1 The widespread use of advanced (physiologic pH, biocompatible bicarbonate/lactate-buffered) peritoneal dialysis solution in Korea has permitted the development of observational data sets that have been used to study the impact of these solutions on patient mortality. In our previous study, which used a data set of 2,163 patients enrolled from 54 Korean centers, we observed a significant association between improved patient survival and use of an advanced peritoneal dialysis solution. | - |
dc.description.statementOfResponsibility | open | - |
dc.relation.isPartOf | AMERICAN JOURNAL OF KIDNEY DISEASES | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Glucans/therapeutic use* | - |
dc.subject.MESH | Glucose/therapeutic use* | - |
dc.subject.MESH | Hemodialysis Solutions/therapeutic use* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Peritoneal Dialysis* | - |
dc.subject.MESH | Proportional Hazards Models | - |
dc.subject.MESH | Survival Rate | - |
dc.subject.MESH | Time Factors | - |
dc.title | Survival Advantage of Icodextrin Peritoneal Dialysis Solution in a Time-Dependent Model | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Song Vogue Ahn | - |
dc.contributor.googleauthor | Edward Vonesh | - |
dc.contributor.googleauthor | Seung Hyeok Han | - |
dc.identifier.doi | 10.1053/j.ajkd.2012.10.007 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A04304 | - |
dc.relation.journalcode | J00089 | - |
dc.identifier.eissn | 1523-6838 | - |
dc.identifier.pmid | 23157934 | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S0272638612013273 | - |
dc.subject.keyword | Female | - |
dc.subject.keyword | Glucans/therapeutic use* | - |
dc.subject.keyword | Glucose/therapeutic use* | - |
dc.subject.keyword | Hemodialysis Solutions/therapeutic use* | - |
dc.subject.keyword | Humans | - |
dc.subject.keyword | Male | - |
dc.subject.keyword | Peritoneal Dialysis* | - |
dc.subject.keyword | Proportional Hazards Models | - |
dc.subject.keyword | Survival Rate | - |
dc.subject.keyword | Time Factors | - |
dc.contributor.alternativeName | Han, Seung Hyeok | - |
dc.contributor.affiliatedAuthor | Han, Seung Hyeok | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 61 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 351 | - |
dc.citation.endPage | 352 | - |
dc.identifier.bibliographicCitation | AMERICAN JOURNAL OF KIDNEY DISEASES, Vol.61(2) : 351-352, 2013 | - |
dc.identifier.rimsid | 28831 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.